ZINPLAVA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ZINPLAVA drug offered from Merck Sharp & Dohme Corp.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | bezlotoxumab |
| SUBSTANCE NAME: | BEZLOTOXUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-10-21 |
| END MARKETING DATE: | 0000-00-00 |
ZINPLAVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZINPLAVA from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2016-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-3025_d6c5254f-8153-4861-b4ad-6f439fed4b63 |
| PRODUCT NDC: | 0006-3025 |
| APPLICATION NUMBER: | BLA761046 |
Other BEZLOTOXUMAB Pharmaceutical Manufacturers / Labelers:
